Safety and Tolerability of Propiverine Hydrochloride in Patients with Severe Renal Impairment (SRI)
Blume H1, Schug B1, Wonnemann M1, Donath F2 1. SocraTec R&D GmbH, Oberursel, 2. APOGEPHA Arzneimittel GmbH
|
|
Abstract 301
|
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 17
|
|
|